|
2025
|
Invention
|
Method of treatment of symptoms of menopause.
The present invention generally relates to novel p... |
|
2023
|
Invention
|
Method of treatment of symptoms of menopause. The present invention generally relates to novel ph... |
|
2021
|
Invention
|
Novel uses.
This invention relates to new use of dual NK-1/NK-3 receptor antagonists or a pharma... |
|
2020
|
Invention
|
New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key interme... |
|
|
Invention
|
Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule co... |
|
2019
|
Invention
|
Soft gelatin capsule formulation. The present invention generally relates to novel pharmaceutical... |
|
|
Invention
|
Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists. The present inve... |
|
|
Invention
|
Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists. NHN,N,2- dimethy... |
|
2016
|
Invention
|
Uses of dual nk1/nk3 receptor antagonists for treating sex-hormone diseases. This invention relat... |
|
|
Invention
|
Dual nk-1/nk-3 receptor antagonists for the treatment of sex-hormone-dependent diseases. This inv... |
|
2011
|
Invention
|
Pyridine derivatives and their use in the treatment of psychotic disorders. A method of treatment... |
|
2010
|
Invention
|
N,2-dimethyl-propanamide of the formula (i), their use in therapy, and process for the preparatio... |
|
|
Invention
|
Anhydrate forms of a pyridine derivative. The invention relates to the compound of formula (I) in... |
|
2009
|
Invention
|
Pyridine derivatives and their use in the treatment of psychotic disorders. A pyridine derivative... |
|
|
Invention
|
Crystalline forms of a pyridine derivative. The invention relates to 4-methylbenzenesulfonate sal... |
|
2006
|
Invention
|
Pyridine derivatives and their use in the treatment of psychotic disorders. There are provided ac... |
